Yes of course. However, given the dire financial position I'm sure they would ideally like to get some up front cash in to be able to discuss on the conference call. Based on the initial words at the time the deal was announced, one might have expected they would be done by now. I still have major doubts about this but I could be wrong.
I am certainly not an expert, but I am following all of you very carefully. Thanks for all the opinions and input. What makes me really wonder how this kind of company setups work. They manage to burn 500 mln $ in 15 years, every year shareholders are disappointed. The CC's are crap. They run out of cash. Then they get money from Lincoln which will be not enough to survive the whole year. On top they are shopping and acquire another company and now everyone is waiting for a partnership or again for a bad Blabla Hedrick CC.
How they manage to get the money. With this history, are there really enough retail investors to steal the money from?
I mean if I own a credit card and I exceed my limit I will not get any money from any bank, isn't it? I illustrate this very plain to get my conclusions. Either their story, even after 15 years, is so convincing or they are top salesmen and third option is: they are simply a scam in a nice complex Pharma shell... we will see...
What's up with the annual CC?
16 Mar 2017 19:26 #9015
Trust that there are a lot of very angry and suspicious people as result. Also trust that you couldn't pay me the 500 million they've burned of other people's money to be in Marc Hedrick's shoes right now.
Starting with the topic "When will they report" March 6th it seemed obvious they would use their later SEC allowable filing time.
Further tea leaf reading suggest there may not be much to look forward to.
After making the rounds in the US the PPS kept falling and the pump in Asia didn't provide much of a rebound either.
The good news is for now we seemed to have at least stabilized but below key bullish levels.
Total crap shoot that there is some glimmer of believable news possible at the end of the month
Rare that someone doesn't know ahead of time...so our history is a valid concern...hope I am wrong.
Still time I guess.
Note, no news yet the Azaya debt has been paid either...I believe they have past their 30 days.
Major revisions are coming. No MAP revenue is a big one for 2017. Adjustments down at Okyanos. I have no clue about Azaya in 2019. 2017 will be modeled after company guidance as it as last year. 2018 to 2020 will reflect numbers that would say "if they can't do this amount of revenue with FDA approvals and insurance reimbursement, then why bother in the first place."
Even though another year has past, I am not going to project past 2020. I will also be comparing my numbers to Maxim and B. Riley.
Interesting on the zero for 2017 MAP, DOV.
I've extended my personal MAP projection out from 2018 to 2019 with the drastic reduction in numbers treated to 2 to 10 patients in total from now through 2019. A big factor in my thinking is no reduction in price charged for these self pay patients.
I have also recently questioned how many patients the will be treating in scleroderma post approval and reimbursement. I am sensing the same question in your post. Did I miss read that ?
BTW...when reducing numbers in your spread sheet why not revisit the burn treatment numbers.
The comparison between Maxim, B Riley and you should be interesting.
You hit the nail on the head. they are a scam in a Pharma shell. The scam has been perpetuated by many who post on this board and perhaps even by the very existence of this board. Investors have been bilked out of millions and for the most part they are retail investors. Some would argue big players have been hurt, but it is clear to me that they were shorts and while the appearance is that they invested, I am certain that upon investigation the truth will be uncovered. It won't matter because this company with be bankrupt and the SEC could care less. If many of the shareholders on this board who claim to have lost big bucks yet continue to buy were truthful they would have agreed to jion a class action long ago. Instead you wait for posts from so called experts to fan the fires of hope. SCAM.
The idea of a class action lawsuit from a current shareholder is counterproductive. The shareholder would be suing himself. Furthermore given the state of Cytori's balance sheet it is unlikely that any lawyer would bother to pursue this on a contingency basis. It only takes one law firm and one shareholder to get it going Roth so you could have done it already if you really wanted to.
I pretty much ignore rothco's class action rantings after what, 2 years and nothing ???
However, I do believe there has been a broader sense from investors on what will really be possible here. I consider that a small net positive.
I've often wonder why Roth has not pulled the plug and go. If one is that negative on a stock, why hang around?
Some of the information he has presented has been good but I don't see the necessity in the constant doom and gloom. If he has some relevant information, even if it's negative, then that's great however, hanging onto a stock while considering even positive information to be a scam seems to be a case of taking comfort in misery.
I enjoy this board for the information that is presented by many that are tremendously more knowledgeable on the technology than I am.
"they are simply a scam in a nice complex Pharma shell"
PT Barnum once said "there is sucker born every day" So the old timers here are in denial and hate the fact that they were snookered holding on to hope that there is a minuscule chance that there is some validity to the science. Then there is the false sense of "illogic" that this management especially, as well as those iterations of the past were just not capable of driving the science to profitability. Yes a long shot. A very long shot. Holding lottery tickets in the corner of your desk drawer like a scorned imbecile. And then we see other "investors" who are clearly aware of the history of this debacle continue to fund its absurdity? Yes as I have always said Cytori is an enigma. An interesting study in the machinations of the casino we call a stock market.